Ralph at Noble was pitch perfect, as he always is...boring, but supremely competent. The potential here is astounding. If sales potential is $500+ million to an acquirer, that should absolutely yield a 6x multiple, $3B. We sit at 26M share count... assume it goes up 20% to 32M, that's close to $100/share. That is a very, very reasonable projection. It goes up from there depending on additional targeted indications, ie. beyond ALS and MS. A potential Hum-Dinger of a sleeper stock. Could be one of the biggest market movers by year-end.
News 
Market Data 
Discover 
